The Association Between BRAF Mutation Class and Clinical Features in BRAF-Mutant Chinese Non-Small Cell Lung Cancer Patients

被引：0
|
作者：
Lin, Q. [1 ]
Zhu, H. [2 ]
Li, Y. [1 ]
Zhang, H. [3 ]
Ding, H. [4 ]
Qian, J. [5 ]
Han-Zhang, H. [6 ]
Lin, J. [6 ]
Xiang, J. [6 ]
机构：
[1] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Wenzhou, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China
[3] Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China
[4] Ningbo Diagnost Pathol Ctr, Ningbo, Zhejiang, Peoples R China
[5] Nanjing Med Univ, Affiliated Suzhou Hosp, Suzhou, Peoples R China
[6] Burning Rock Biotech, Guangzhou, Guangdong, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Chinese; braf; NSCLC;
D O I：
10.1016/j.jtho.2019.08.735
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.01-20
引用
收藏
页码：S363 / S363
页数：1
相关论文
共 50 条
  • [41] BRAF MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER: A POOLED ANALYSIS
    Huang, Z. -M.
    An, S. -J.
    Huang, L.
    Wu, Y. -L.
    ANNALS OF ONCOLOGY, 2012, 23 : 48 - 48
  • [42] Dabrafenib in patients with BRAF-mutated non-small cell lung cancer
    Kawamura, Takahisa
    Murakami, Haruyasu
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S342 - S344
  • [43] BRAF MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER: A POOLED ANALYSIS
    Huang, Zhi-min
    An, She J.
    Wu, Yi-long
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S458 - S458
  • [44] A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancer
    Planchard, David
    Wolf, Juergen
    Solomon, Benjamin
    Sebastian, Martin
    Wermke, Martin
    Heist, Rebecca S.
    Sun, Jong-Mu
    Kim, Tae Min
    Reguart, Noemi
    Sanmamed, Miguel F.
    Felip, Enriqueta
    Garrido, Pilar
    Santoro, Armando
    Bootle, Douglas
    Couillebault, Xuan-Mai
    Gaur, Anil
    Mueller, Christina
    Poggio, Teresa
    Yang, Jie
    Moschetta, Michele
    Dooms, Christophe
    LUNG CANCER, 2024, 197
  • [45] Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Harboring BRAF Mutations
    Marchetti, Antonio
    Felicioni, Lara
    Malatesta, Sara
    Sciarrotta, Maria Grazia
    Guetti, Luigi
    Chella, Antonio
    Viola, Patrizia
    Pullara, Carmela
    Mucilli, Felice
    Buttitta, Fiamma
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (26) : 3574 - 3579
  • [46] Resistance mechanisms to BRAF inhibition identified by single circulating tumor cell and cell-free tumor DNA molecular profiling in BRAF-mutant non-small cell lung cancer.
    Mezquita, Laura
    Oulhen, Marianne
    Aberlenc, Agathe
    Deloger, Marc
    Honore, Aurelie
    Garonzi, Marianna
    Buson, Genny
    Forcato, Claudio
    Lecluse, Yann
    Aldea, Mihaela
    NgoCamus, Maud
    Nicotra, Claudio
    Howarth, Karen
    Lacroix, Ludovic
    Friboulet, Luc
    Besse, Benjamin
    Manaresi, Nicolo
    Planchard, David
    Farace, Francoise
    CANCER RESEARCH, 2021, 81 (13)
  • [47] BRAF mutation predicts MEK-dependence in non-small cell lung cancer (NSCLC)
    Pratilas, Christine A.
    Halilovic, Ensar
    Persaud, Yogindra
    Sawai, Ayana
    Grbovic-Huezo, Olivera
    Janakiraman, Manickam
    Rosen, Neal
    Solit, David B.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3595S - 3595S
  • [48] BRAF mutation predicts MEK-dependence in non-small cell lung cancer (NSCLC)
    Pratilas, C. A.
    Halilovic, E.
    Sawai, A.
    Grbovic-Huezo, O.
    Rosen, N.
    Solit, D. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [49] BRAF in non-small cell lung cancer: From molecular mechanisms to clinical practice
    Parisi, Claudia
    Planchard, David
    CANCER, 2025, 131
  • [50] BRAF AND PIK3CA GENE MUTATION STATUS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Chen, Zhi-Hong
    An, She-Juan
    Xie, Zhi
    Guo, Ai-Lin
    Chen, Jian-Guang
    Yan, Hong-Hong
    Su, Jian
    Chen, Zhi-Yong
    Nang, Xu-Chao
    Wu, Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S989 - S990
12345